Use of the nuclear matrix protein 22 Bladder Chek test (TM) in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer

Balci, Melih; Tuncel, Altug; Guzel, Ozer; Aslan, Yilmaz; Sezgin, Tezcan; Bilgin, Ovunc; Senel, Cagdas; Atan, ALİ

doi:10.1007/s11255-015-0921-4

Use of the nuclear matrix protein 22 Bladder Chek test (TM) in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer

Copy For Citation

Balci M., Tuncel A., Guzel O., Aslan Y., Sezgin T., Bilgin O., ...More

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.47, no.3, pp.473-477, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 47 Issue: 3
Publication Date: 2015
Doi Number: 10.1007/s11255-015-0921-4
Journal Name: INTERNATIONAL UROLOGY AND NEPHROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.473-477
Keywords: Bladder cancer, Diagnosis, NMP-22, Cytology, Second TUR
Gazi University Affiliated: Yes

Abstract

To investigate the diagnostic value of the nuclear matrix protein 22 (NMP-22) in residual tumors after complete transurethral resection (TUR) of bladder cancer.